Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammed Moudjou

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Transfusion|May 15, 2024
Characterization of the 263K-derived microsomal fraction: a source of prions for nanofiltration validation studiesSteve Simoneau, Angélique Igel, Danica Ciric, et al.
Prion|December 13, 2012
Mammalian prions: tolerance to sequence changes-how far?Muhammad Khalid Salamat, Carola Munoz-Montesino, Mohammed Moudjou, et al.
The Journal of Biological Chemistry|February 16, 2010
Endogenous proteolytic cleavage of disease-associated prion protein to produce C2 fragments is strongly cell- and tissue-dependentMichel Dron, Mohammed Moudjou, Jérôme Chapuis, et al.
Journal of Virology|August 17, 2004
Glycan-controlled epitopes of prion protein include a major determinant of susceptibility to sheep scrapieMohammed Moudjou, Eric Treguer, Human Rezaei, et al.
Biochemical and Biophysical Research Communications|October 11, 2005
Prion proteins from susceptible and resistant sheep exhibit some distinct cell biological featuresElifsu Sabuncu, Sophie Paquet, Jérome Chapuis, et al.
Plos One|June 2, 2012
Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccineAude Remot, Xavier Roux, Catherine Dubuquoy, et al.
Frontiers in Bioengineering and Biotechnology|December 18, 2020
Improving the Predictive Value of Prion Inactivation Validation Methods to Minimize the Risks of Iatrogenic Transmission With Medical InstrumentsMohammed Moudjou, Johan Castille, Bruno Passet, et al.
The Journal of Biological Chemistry|April 19, 2012
Integrity of helix 2-helix 3 domain of the PrP protein is not mandatory for prion replicationKhalid Salamat, Mohammed Moudjou, Jérôme Chapuis, et al.
Molecular Neurobiology|April 3, 2020
Crossing Species Barriers Relies on Structurally Distinct Prion Assemblies and Their ComplementationAngélique Igel-Egalon, Florent Laferrière, Philippe Tixador, et al.
Plos Pathogens|October 17, 2013
Quaternary structure of pathological prion protein as a determining factor of strain-specific prion replication dynamicsFlorent Laferrière, Philippe Tixador, Mohammed Moudjou, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Transfusion|May 15, 2024
Characterization of the 263K-derived microsomal fraction: a source of prions for nanofiltration validation studiesSteve Simoneau, Angélique Igel, Danica Ciric, et al.
Prion|December 13, 2012
Mammalian prions: tolerance to sequence changes-how far?Muhammad Khalid Salamat, Carola Munoz-Montesino, Mohammed Moudjou, et al.
The Journal of Biological Chemistry|February 16, 2010
Endogenous proteolytic cleavage of disease-associated prion protein to produce C2 fragments is strongly cell- and tissue-dependentMichel Dron, Mohammed Moudjou, Jérôme Chapuis, et al.
Journal of Virology|August 17, 2004
Glycan-controlled epitopes of prion protein include a major determinant of susceptibility to sheep scrapieMohammed Moudjou, Eric Treguer, Human Rezaei, et al.
Biochemical and Biophysical Research Communications|October 11, 2005
Prion proteins from susceptible and resistant sheep exhibit some distinct cell biological featuresElifsu Sabuncu, Sophie Paquet, Jérome Chapuis, et al.
Plos One|June 2, 2012
Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccineAude Remot, Xavier Roux, Catherine Dubuquoy, et al.
Frontiers in Bioengineering and Biotechnology|December 18, 2020
Improving the Predictive Value of Prion Inactivation Validation Methods to Minimize the Risks of Iatrogenic Transmission With Medical InstrumentsMohammed Moudjou, Johan Castille, Bruno Passet, et al.
The Journal of Biological Chemistry|April 19, 2012
Integrity of helix 2-helix 3 domain of the PrP protein is not mandatory for prion replicationKhalid Salamat, Mohammed Moudjou, Jérôme Chapuis, et al.
Molecular Neurobiology|April 3, 2020
Crossing Species Barriers Relies on Structurally Distinct Prion Assemblies and Their ComplementationAngélique Igel-Egalon, Florent Laferrière, Philippe Tixador, et al.
Plos Pathogens|October 17, 2013
Quaternary structure of pathological prion protein as a determining factor of strain-specific prion replication dynamicsFlorent Laferrière, Philippe Tixador, Mohammed Moudjou, et al.
Pageof 5